Understanding endometriosis in Black women
Risk factors for and consequences of endometriosis among Black women
['FUNDING_R21'] · FRED HUTCHINSON CANCER CENTER · NIH-10872650
This study is looking at how endometriosis affects Black women, focusing on the unique challenges they face in getting diagnosed and treated, so we can better understand their experiences and improve care for them.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10872650 on ClinicalTrials.gov |
What this research studies
This research investigates the risk factors and consequences of endometriosis specifically among Black women, a group that has been underrepresented in previous studies. It aims to identify disparities in diagnosis and access to care, as well as how various biological and social factors may influence the prevalence and impact of endometriosis in this population. By analyzing data on health outcomes and risk factors, the research seeks to fill critical gaps in knowledge and improve understanding of how endometriosis affects Black women throughout their lives.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women who experience symptoms of endometriosis or have been diagnosed with the condition.
Not a fit: Patients who are not Black women or those who do not have endometriosis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for Black women suffering from endometriosis.
How similar studies have performed: While there has been limited research specifically on endometriosis in Black women, studies on health disparities in other conditions have shown that targeted research can lead to significant improvements in understanding and treatment.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HARRIS, HOLLY RUTH — FRED HUTCHINSON CANCER CENTER
- Study coordinator: HARRIS, HOLLY RUTH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases